UK vein treatment specialist VeinCentre has opened its first clinic in Northern Ireland, establishing a presence in south Belfast as the chain expands its network of dedicated vein care facilities across the UK.

According to a report by the Belfast Telegraph, VeinCentre opened on Stranmillis Road last week, representing the chain's 44th site in the UK. The business described the Northern Ireland opening as a milestone, with care at the Belfast clinic led by vascular surgeon Colin Weir, a Queen's University graduate with more than 25 years of experience across NHS and private practice.

Colin Weir said: "As the UK's largest vein specialist, we're proud to be expanding our network of dedicated vein clinics and bringing expert vein care closer to home for patients across Northern Ireland. Our Belfast team is ready to see patients from consultation through to treatment and follow-up, delivering the specialist care and expertise that VeinCentre is known for."

The clinic offers walk-in, walk-out procedures conducted under local anaesthetic and typically completed in under two hours. The most common treatment offered is Endovenous Laser Ablation, described by VeinCentre as a minimally invasive procedure that closes the faulty vein using targeted laser energy. Patients move through consultation, treatment, and follow-up care within the same clinic.

Weir noted that millions of adults live with the pain and discomfort of varicose veins without realising that treatment is available and accessible, adding that the Belfast clinic is intended to make advanced treatment easier to access for patients across Northern Ireland.

Varicose veins occur when valves inside the veins weaken or become damaged, causing blood to pool rather than flow efficiently back to the heart. Symptoms can include aching, heaviness, swelling, and visible bulging veins in the legs.

For private healthcare operators, the VeinCentre Belfast opening reflects a broader trend of specialist procedure-focused clinics expanding into regional markets across the UK and Ireland, where demand for minimally invasive, outpatient vascular treatments continues to grow among patients seeking alternatives to NHS waiting lists.